Quadria Capital sells entire stake in Akums for Rs 311 crore
New Delhi: In a significant market deal, Singapore-based private equity firm Quadria Capital has exited Akums Drugs and Pharmaceuticals, selling its entire 4.62 per cent stake in the company for over Rs 311 crore through an open market transaction.
According to block deal data available on the NSE, Quadria Capital, through its arm Ruby QC Investment Holdings Pte Ltd, offloaded over 72.78 lakh shares of Akums.
The shares were disposed of at an average price of Rs 428 apiece, valuing the transaction at Rs 311.52 crore, PTI reported.
Read also: Akums Drugs & Pharma appoints Yuvraj Datta as President - Operational Strategy & Excellence
Meanwhile, ICICI Prudential Mutual Fund purchased the same number of shares at the same price, the NSE data showed.
Akums is a contract development and manufacturing organisation.
Next Story